Towerpoint Wealth LLC Boosts Position in UnitedHealth Group Incorporated (NYSE:UNH)

Towerpoint Wealth LLC lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.2% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 911 shares of the healthcare conglomerate’s stock after buying an additional 28 shares during the quarter. Towerpoint Wealth LLC’s holdings in UnitedHealth Group were worth $451,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Scharf Investments LLC raised its position in UnitedHealth Group by 6.4% in the 1st quarter. Scharf Investments LLC now owns 3,728 shares of the healthcare conglomerate’s stock valued at $1,844,000 after purchasing an additional 224 shares during the last quarter. Procyon Advisors LLC raised its holdings in shares of UnitedHealth Group by 2.2% in the first quarter. Procyon Advisors LLC now owns 22,033 shares of the healthcare conglomerate’s stock valued at $10,900,000 after buying an additional 483 shares during the last quarter. ERn Financial LLC boosted its stake in shares of UnitedHealth Group by 0.9% during the first quarter. ERn Financial LLC now owns 2,784 shares of the healthcare conglomerate’s stock worth $1,377,000 after buying an additional 25 shares during the period. Franklin Street Advisors Inc. NC raised its stake in UnitedHealth Group by 27.1% during the 1st quarter. Franklin Street Advisors Inc. NC now owns 2,319 shares of the healthcare conglomerate’s stock valued at $1,147,000 after acquiring an additional 495 shares during the last quarter. Finally, Janiczek Wealth Management LLC grew its stake in shares of UnitedHealth Group by 4.7% in the 1st quarter. Janiczek Wealth Management LLC now owns 1,814 shares of the healthcare conglomerate’s stock valued at $897,000 after purchasing an additional 82 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

UNH has been the subject of several recent research reports. Piper Sandler increased their price target on UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. Cantor Fitzgerald reiterated an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a research note on Wednesday, June 12th. Barclays raised their price objective on shares of UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. Deutsche Bank Aktiengesellschaft increased their target price on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Finally, Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Three equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $579.74.

UnitedHealth Group Trading Up 2.6 %

Shares of UNH opened at $499.25 on Friday. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70. The stock has a fifty day moving average of $498.30 and a two-hundred day moving average of $502.61. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85. The company has a market capitalization of $459.50 billion, a PE ratio of 29.74, a price-to-earnings-growth ratio of 1.40 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same period in the prior year, the firm posted $6.26 EPS. The company’s revenue was up 8.6% on a year-over-year basis. As a group, analysts forecast that UnitedHealth Group Incorporated will post 27.57 EPS for the current year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, June 17th. This represents a $8.40 dividend on an annualized basis and a yield of 1.68%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.